The site in Køge, Denmark, where Novo Nordisk Pharmatech plans to build a new API manufacturing site (Novo Nordisk)
August 16, 2024 08:16 AM EDTUpdated 12:54 PM
Manufacturing

No­vo Nordisk sub­sidiary to build $220M API fa­cil­i­ty for chron­ic dis­ease drugs

Anna Brown

News Reporter

No­vo Nordisk Phar­mat­e­ch is build­ing a new fa­cil­i­ty in Den­mark to ex­pand ca­pac­i­ty for raw ma­te­r­i­al pro­duc­tion due to “sig­nif­i­cant­ly high­er de­mand” from its par­ent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

FDA is poised to pull Ocali­va as ad­comm doc­u­ments ques­tion post-ap­proval study re­sults

FDA crit­i­cizes Ab­b­Vie's 'mis­lead­ing' ad with Ser­e­na Williams

CVS says it won't cor­rect con­gres­sion­al tes­ti­mo­ny

Roche says its Car­mot-ac­quired obe­si­ty pill is ef­fec­tive in ear­ly study

No­vo Nordisk's long­stand­ing GLP-1 re­duced BMI by 7% in chil­dren in Phase 3 tri­al

Sanofi, Re­gen­eron to re­file Dupix­ent for skin con­di­tion af­ter new study win

A service from the Financial Times